Gilead Sciences, Inc. v. Mylan Pharmaceuticals Inc.
Gilead Sciences, Inc. |
Mylan Pharmaceuticals Inc. |
1:2017cv00036 |
March 3, 2017 |
US District Court for the Northern District of West Virginia |
Clarksburg Office |
XX US, Outside State |
Irene M Keeley |
Patent |
35 U.S.C. § 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on July 23, 2018. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 37 REPORT to USPTO on the filing or determination of an action regarding re #36 ORDER ON STIPULATION of Dismissal, #1 Complaint. (jmm) |
|
Filing 35 STIPULATION of Dismissal by Mylan Pharmaceuticals Inc.. (Attachments: #1 Exhibit A - Proposed Order On Stipulation For Dismissal)(O'Brien, William) |
|
Filing 33 Joint MOTION to Stay Case by Gilead Sciences, Inc.. (Attachments: #1 Text of Proposed Order)(Taylor, Chad) |
|
Filing 31 Pro Hac Vice Filing fee: for A. Allen $ 200.00, receipt number WVNC001909 (jss) |
Filing 30 MOTION for Leave to Appear Pro Hac Vice (Aden M. Allen) by Mylan Pharmaceuticals Inc.. (Attachments: #1 Text of Proposed Order)(Copland, Gordon) |
|
|
|
Filing 26 Pro Hac Vice fee for N. Stafford, R. Delafield, and G. Pak: $ 600.00, receipt number WVNC001908. (cnd) |
Filing 25 MOTION for Leave to Appear Pro Hac Vice (Grace J. Pak) by Mylan Pharmaceuticals Inc.. (Attachments: #1 Text of Proposed Order)(Copland, Gordon) |
Filing 24 Corporate Disclosure Statement by Mylan Pharmaceuticals Inc. identifying Corporate Parent Mylan Inc., Corporate Parent Mylan N.V. for Mylan Pharmaceuticals Inc... (O'Brien, William) |
Filing 23 ANSWER to #1 Complaint by Mylan Pharmaceuticals Inc..(O'Brien, William) |
Filing 22 MOTION for Leave to Appear Pro Hac Vice (Robert A. Delafield) by Mylan Pharmaceuticals Inc.. (Attachments: #1 Text of Proposed Order)(Copland, Gordon) |
Filing 21 MOTION for Leave to Appear Pro Hac Vice (Nicole W. Stafford) by Mylan Pharmaceuticals Inc.. (Attachments: #1 Text of Proposed Order)(Copland, Gordon) |
Filing 20 NOTICE of Appearance by William J O'Brien on behalf of Mylan Pharmaceuticals Inc. (O'Brien, William) |
Filing 19 STIPULATION Regarding Responsive Pleading by Mylan Pharmaceuticals Inc.. (Copland, Gordon) |
|
Filing 17 SUMMONS Returned Executed as to Mylan Pharmaceuticals Inc. served on 5/9/2017. (cnd) |
|
|
|
|
|
Filing 10 Pro Hac Vice Filing fees for R. Horwitz, A. Mortara, J. Heaton, N. Gerwertz and S. McBride: $ 1,000.00, receipt number WVNC001835 (jss) |
Filing 9 MOTION for Leave to Appear Pro Hac Vice of Rebecca T. Horwitz by Gilead Sciences, Inc.. (Attachments: #1 Text of Proposed Order)(Taylor, Chad) |
Filing 8 MOTION for Leave to Appear Pro Hac Vice of Adam K. Mortara by Gilead Sciences, Inc.. (Attachments: #1 Text of Proposed Order)(Taylor, Chad) |
Filing 7 MOTION for Leave to Appear Pro Hac Vice of James B. Heaton III by Gilead Sciences, Inc.. (Attachments: #1 Text of Proposed Order)(Taylor, Chad) |
Filing 6 MOTION for Leave to Appear Pro Hac Vice of Nevin M. Gewertz by Gilead Sciences, Inc.. (Attachments: #1 Text of Proposed Order)(Taylor, Chad) |
Filing 5 MOTION for Leave to Appear Pro Hac Vice of J. Scott McBride by Gilead Sciences, Inc.. (Attachments: #1 Text of Proposed Order)(Taylor, Chad) |
Filing 4 VERIFICATION OF ATTORNEY ADMISSION. (jss) |
Filing 3 REPORT to USPTO on the filing or determination of an action regarding re #1 Complaint. (jss) |
Filing 2 Corporate Disclosure Statement by Gilead Sciences, Inc. (jss) |
Filing 1 COMPLAINT against Mylan Pharmaceuticals Inc. filed by Gilead Sciences, Inc. Filing Fee $400 - PAID - Receipt #0424-2305504 (Attachments: #1 Civil Cover Sheet)(jss) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.